MedPath

A Trial to Study Neladenoson Bialanate Over 20 Weeks in Patients With Chronic Heart Failure With Preserved Ejection Fraction

Phase 2
Completed
Conditions
Heart Failure
Interventions
Drug: Neladenoson bialanate (BAY1067197)
Drug: Placebo
Registration Number
NCT03098979
Lead Sponsor
Bayer
Brief Summary

The objective of the study is to find the optimal dose of once daily oral neladenoson bialanate (BAY1067197) when given in addition to appropriate therapy for specific comorbidities.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
305
Inclusion Criteria
  • Men or women aged 45 years and older
  • Diagnosis of chronic heart failure, NYHA (New York Heart Association) class II-IV, LVEF (left ventricular ejection fraction) ≥ 45% and elevated NT-proBNP
Read More
Exclusion Criteria
  • Acute decompensated heart failure within the past 4 weeks
  • Inability to exercise
  • Previous diagnosis of HFrEF (heart failure with reduced ejection fraction) (LVEF < 40%)
Read More

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Neladenoson bialanate (BAY1067197) (5 mg)Neladenoson bialanate (BAY1067197)Chronic heart failure with preserved ejection fraction
Neladenoson bialanate (BAY1067197) (10 mg)Neladenoson bialanate (BAY1067197)Chronic heart failure with preserved ejection fraction
Neladenoson bialanate (BAY1067197) (20 mg)Neladenoson bialanate (BAY1067197)Chronic heart failure with preserved ejection fraction
Neladenoson bialanate (BAY1067197) (30 mg)Neladenoson bialanate (BAY1067197)Chronic heart failure with preserved ejection fraction
Neladenoson bialanate (BAY1067197) (40 mg)Neladenoson bialanate (BAY1067197)Chronic heart failure with preserved ejection fraction
PlaceboPlaceboChronic heart failure with preserved ejection fraction
Primary Outcome Measures
NameTimeMethod
Absolute Change From Baseline in 6-minute Walking Distance (6MWD) After 20 Weeks of TreatmentBaseline, and up to 20 weeks of treatment

The 6MWD test is designed to evaluate a subject's exercise capacity while performing an everyday activity.

Secondary Outcome Measures
NameTimeMethod
Measured Values (Log-transformed) and Absolute Change in High Sensitivity Troponin T (Hs-TNT) From Baseline to 20 WeeksBaseline, and up to 20 weeks of treatment

High sensitivity troponin T (hs-TNT) was measured

Measured Values and Absolute Change in 3 Scores From Kansas City Cardiomyopathy Questionnaire (KCCQ) From Baseline to 20 Weeks: Overall Summary Score, Physical Limitation Score and Total Symptom ScoreBaseline, and up to 20 weeks of treatment

The KCCQ is the leading health-related quality-of-life measure for patients with chronic heart failure (CHF). It is a 23-item questionnaire that independently measures the impact of patient's heart failure (HF), or its treatment, on 7 distinct domains: 1) Symptom Frequency 2) Symptom Burden 3) Physical Limitation 4) Quality of Life 5) Social Limitations 6) Self-efficacy 7) Symptoms Stability.

Overall summary score= mean score of (symptom frequency + symptom burden+ physical limitation + quality of life + social limitation); scores on a scale of 0 to 100, higher scores means better outcome; Physical Limitation: scores on a scale of 0 to 100, higher scores means better outcome; Total symptom score=mean score of (symptom frequency + symptom burden): scores on a scale of 0 to 100, higher scores means better outcome.

Positive change means improvement and negative change means deterioration.

Change From Baseline in Average Weekly Percentage of Maximum Possible Recorded Activity IntensityBaseline, and up to 20 weeks of treatment

AVIVO™ Mobile Patient Management System, a wearable wireless device worn by the subject, was used to monitor subjects' cardiovascular status. The patient's everyday physical activity e.g. duration, intensity, was also tracked by the AVIVO device. For Activity Intensity, the Unit of Measure is "percentage of maximum activity", and length of intervals is "daily".

Measured Values (Log Transformed) and Absolute Change in NT-proBNP From Baseline to 20 WeeksBaseline, and up to 20 weeks of treatment

NT-proBNP = N-terminal pro-hormone b-type natriuretic peptide

Trial Locations

Locations (76)

BryanLGH Medical Center East

🇺🇸

Lincoln, Nebraska, United States

General Hospital of Chalkida

🇬🇷

Chalkida, Greece

Krankenhaus der Elisabethinen Linz GmbH

🇦🇹

Linz, Oberösterreich, Austria

KAT General Hospital of Athens

🇬🇷

Kifisia / Athens, Attica, Greece

Medizinische Universität Graz

🇦🇹

Graz, Steiermark, Austria

Specialized Hospital for Actrive Treatm of Card - Pleven

🇧🇬

Pleven, Bulgaria

Universitätsklinikum St. Pölten

🇦🇹

St. Pölten, Niederösterreich, Austria

CHLO - Hospital São Francisco Xavier

🇵🇹

Lisboa, Portugal

MCOMH Preventsia-2000

🇧🇬

Stara Zagora, Bulgaria

Hospital da Luz

🇵🇹

Lisboa, Portugal

Shaare Zedek Medical Center

🇮🇱

Jerusalem, Israel

Wake Forest Baptist Health

🇺🇸

Winston-Salem, North Carolina, United States

G. Gennimatas General State Hospital of Athens

🇬🇷

Athens, Greece

Rambam Health Corporation

🇮🇱

Haifa, Israel

Hadassah University Hospital Mount Scopus

🇮🇱

Jerusalem, Israel

Tel-Aviv Sourasky Medical Center

🇮🇱

Tel Aviv, Israel

Hospital Virgen de la Victoria

🇪🇸

Málaga, Spain

Krankenhaus Hietzing

🇦🇹

Wien, Austria

Northwestern University

🇺🇸

Chicago, Illinois, United States

St. Louis Heart & Vascular, PC

🇺🇸

Saint Louis, Missouri, United States

Krankenhaus St. Josef Braunau

🇦🇹

Braunau, Oberösterreich, Austria

Allgemeines Krankenhaus der Stadt Wien

🇦🇹

Wien, Austria

Jessa Ziekenhuis

🇧🇪

Hasselt, Belgium

CHR de la Citadelle

🇧🇪

Liege, Belgium

Spec Hosp for Active Treatm in Cardiology Sv Georgi Pernik

🇧🇬

Pernik, Bulgaria

AZ Delta

🇧🇪

Roeselare, Belgium

Medical Center Cardiohelp

🇧🇬

Sofia, Bulgaria

NMTH Tzar Boris III

🇧🇬

Sofia, Bulgaria

UMHAT Tsaritsa Joanna-ISUL EAD Sofia

🇧🇬

Sofia, Bulgaria

Klinische Forschung Dresden GmbH

🇩🇪

Dresden, Sachsen, Germany

St. Vincenz und Elisabeth Hospital, Kathol. Klinikum Mainz

🇩🇪

Mainz, Rheinland-Pfalz, Germany

HELIOS Klinikum Erfurt GmbH

🇩🇪

Erfurt, Thüringen, Germany

Konstantopoulio General Hospital of Nea Ionia - Agia Olga

🇬🇷

Nea Ionia / Athens, Greece

Hippokration General Hospital of Thessaloniki

🇬🇷

Thessaloniki, Greece

Asklipieion General Hospital of Voulas

🇬🇷

Voula, Greece

Barzilai Medical Center

🇮🇱

Ashkelon, Israel

Hillel Yaffe Medical Center

🇮🇱

Hadera, Israel

AAS 3 Friuli Alto Medio Collin

🇮🇹

Udine, Friuli-Venezia Giulia, Italy

Assaf Harofeh Medical Center

🇮🇱

Zrifin, Israel

ASST Spedali Civili di Brescia

🇮🇹

Brescia, Lombardia, Italy

A.O.U. Sant'Andrea

🇮🇹

Roma, Lazio, Italy

ASST Papa Giovanni XXIII

🇮🇹

Bergamo, Lombardia, Italy

A.O. Ordine Mauriziano

🇮🇹

Torino, Piemonte, Italy

AUSL Toscana Sud-Est

🇮🇹

Arezzo, Toscana, Italy

A.O.U. di Sassari

🇮🇹

Sassari, Sardegna, Italy

Hyogo Prefectural Amagasaki General Medical Center

🇯🇵

Amagasaki, Hyogo, Japan

Chuno kosei Hospital

🇯🇵

Seki, Gifu, Japan

Shonan Fujisawa Tokushukai Hospital

🇯🇵

Fujisawa, Kanagawa, Japan

R.I.A.C Naha City Hospital

🇯🇵

Naha, Okinawa, Japan

National Hospital Organization Kanazawa Medical Center

🇯🇵

Kanazawa, Ishikawa, Japan

Kishiwada Tokushukai Hospital

🇯🇵

Kishiwada, Osaka, Japan

Osaka Medical College Hospital

🇯🇵

Takatsuki, Osaka, Japan

Takatsuki Red Cross Hospital

🇯🇵

Takatsuki, Osaka, Japan

Minamino Cardiovascular Hospital

🇯🇵

Hachioji, Tokyo, Japan

Fukui Prefectural Hospital

🇯🇵

Fukui, Japan

Tokyo Women's Medical University Hospital

🇯🇵

Shinjuku-ku, Tokyo, Japan

Okayama Rosai Hospital

🇯🇵

Okayama, Japan

Osaka General Medical Center

🇯🇵

Osaka, Japan

Uniwersytecki Szpital Kliniczny w Bialymstoku

🇵🇱

Bialystok, Poland

Tokushima Prefectural Central Hospital

🇯🇵

Tokushima, Japan

Szpital Zachodni w Grodzisku Mazowieckim

🇵🇱

Grodzisk Mazowiecki, Poland

Szpital Specjalistyczny im. J. Dietla

🇵🇱

Krakow, Poland

109 Szpital Wojskowy z przychodnia SPZOZ

🇵🇱

Szczecin, Poland

Wojewodzki Specjalistyczny Szpital im. dr Wl. Bieganskiego

🇵🇱

Lodz, Poland

Szpital Wolski im. dr Anny Gostynskiej SPZOZ

🇵🇱

Warszawa, Poland

IV Wojskowy Szpital Kliniczny z Poliklinika, SPZOZ

🇵🇱

Wroclaw, Poland

CHUP, EPE - Hospital de Santo Antonio

🇵🇹

Porto, Portugal

CHUC - Hospitais da Universidade de Coimbra

🇵🇹

Coimbra, Portugal

Hospital Universitario "Virgen de la Arrixaca"

🇪🇸

El Palmar, Murcia, Spain

Hospital Sanitas La Zarzuela

🇪🇸

Aravaca, Madrid, Spain

Hospital del Mar

🇪🇸

Barcelona, Spain

Hospital Clínico Universitario San Carlos

🇪🇸

Madrid, Spain

Hospital General Universitario Gregorio Marañón

🇪🇸

Madrid, Spain

Hospital Universitari i Politècnic La Fe

🇪🇸

Valencia, Spain

Hospital Clínico Universitario de Valencia

🇪🇸

Valencia, Spain

Charité Campus Virchow-Klinikum (CVK)

🇩🇪

Berlin, Germany

© Copyright 2025. All Rights Reserved by MedPath